{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:20:22Z","timestamp":1783524022400,"version":"3.55.0"},"reference-count":23,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Diabetic kidney disease (DKD) is one of the leading causes of chronic kidney disease (CKD) worldwide. Individuals over 65 years of age with type 2 diabetes mellitus (T2DM) constitute a growing age group that is frequently underrepresented in randomized clinical trials. Finerenone has been shown to reduce renal progression and cardiovascular events in patients with albuminuric DKD. To evaluate the clinical and laboratory characteristics as well as the therapeutic response and safety profile of finerenone in patients over 65 years of age with DKD, based on data from the FINDKDLATAM observational study cohort. Materials and Methods: Subgroup analysis of a real-life, retrospective, multicenter observational study\u2014the FINDKDLATAM cohort. For the present analysis, patients aged \u2265 65 years were stratified. Sociodemographic, clinical, paraclinical, and treatment variables and adverse events were evaluated. The descriptive analysis used medians with interquartile ranges (IQRs) for continuous variables of non-parametric distribution and absolute and relative frequencies for categorical variables. The comparison of baseline parameters and those at six months of follow-up was performed using non-parametric tests, with statistics. Results: Of the total of 347 patients included in the original study, 157 (45.2%) were \u226565 years of age. The median age was 72 years. The baseline profile showed a median glomerular filtration rate (eGFR) of 38.0 mL\/min\/1.73 m2 (IQR: 30.0\u201350.75), as well as elevated albuminuria (ACR 327.0 mg\/g; IQR: 186.5\u2013805.5). In addition, the patients had a high burden of comorbidities. 58.0% of patients received finerenone at a dose of 10 mg and 42.0% at a dose of 20 mg. After six months of follow-up, a significant reduction in the median ACR was observed, decreasing from 327.0 mg\/g (IQR: 186.5\u2013805.5) to 78.0 mg\/g (IQR: 27.5\u2013143.0), corresponding to a decrease of 76% (p &lt; 0.0001). Regarding safety, hyperkalemia occurred in 20.3% of patients, although, in all cases, it was mild hyperkalemia (potassium between 5.1 and 5.5 mEq\/L), with no serious episodes or treatment suspensions attributable to this event. Conclusions: In this cohort of Latin American adults over 65 years of age with albuminuric DKD, finerenone demonstrated good efficiency given the clinically significant reduction of albuminuria with stable renal function at six months of treatment, also demonstrating a safety profile, with a low risk of hyperkalemia.<\/jats:p>","DOI":"10.3390\/medicina62071317","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:27:23Z","timestamp":1783520843000},"page":"1317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2852-1241","authenticated-orcid":false,"given":"Jorge","family":"Rico Fontalvo","sequence":"first","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Colombian Association of Nephrology and Arterial Hypertension, Bogota 110221, Colombia"},{"name":"Department of Nephrology, Faculty of Medicine, Sim\u00f3n Bol\u00edvar University of Barranquilla, Barranquilla 080001, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Raad Sarabia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, Sim\u00f3n Bol\u00edvar University of Barranquilla, Barranquilla 080001, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9346-2279","authenticated-orcid":false,"given":"Jos\u00e9 C.","family":"De La Flor","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Central de la Defensa G\u00f3mez Ulla, 28047 Madrid, Spain"},{"name":"Department of Medicine and Medical Specialties, Faculty of Medicine, Alcala University of Alcal\u00e1, 28805 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3253-6363","authenticated-orcid":false,"given":"Vicente","family":"S\u00e1nchez Polo","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Faculty of Medicine, Department of Nephrology, University of San Carlos of Guatemala (USAC), Guatemala City 01011, Guatemala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-4147","authenticated-orcid":false,"given":"Jenniffer","family":"Benavides Garcia","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, El Rosario University, Health Science, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Ramos Clason","sequence":"additional","affiliation":[{"name":"Postgraduate Medical and Surgical Research, GIBACUS Research Group, Sin\u00fa University EBZ, Cartagena Campus, Cartagena 130010, Colombia"},{"name":"Faculty of Nursing, Health Services Administration Program, University of Cartagena, 13005 Cartagena, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Department of Nephrology, Del Valle Hospital, Honduras, Rotating Internship at the Catholic University of Honduras, San Pedro Sula 21102, Honduras"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-472X","authenticated-orcid":false,"given":"Giovanny","family":"Mera Rebutti","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Abel Gilbert Pont\u00f3n Hospital of Guayaquil, Ministry of Public Health, O\u2019Connors, Guayaquil 090104, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Madrid Mancia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Honduran Institute of Social Security, North Region, San Pedro Sula 21102, Honduras"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4811-8067","authenticated-orcid":false,"given":"Rene","family":"Tabora L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Del Valle Hospital, Honduras, Rotating Internship at the Catholic University of Honduras, San Pedro Sula 21102, Honduras"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4170-4047","authenticated-orcid":false,"given":"Manuel","family":"Rocha Meza","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Department of Nephrology, Benda\u00f1a Hospital National Autonomous University of Honduras, San Pedro Sula 21102, Honduras"},{"name":"Internal Medicine, Mario Catarino Rivas Hospital, San Pedro Sula 21102, Honduras"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5620-5243","authenticated-orcid":false,"given":"Dany","family":"Tabora L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Del Valle Hospital, Catholic University of Honduras, San Pedro Sula 21102, Honduras"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J. Mu\u00f1oz","family":"Zambrano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rafael Rodr\u00edguez Zambrano Hospital, Manta 130206, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lorca Herrera","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Department of Internal Medicine East, Faculty of Medicine, University of Chile, Providencia, Santiago de Chile 8320000, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Dina-Batlle","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Department of Nephrology, Metropolitan Hospital of Santiago, Santiago de los Caballeros 51000, Dominican Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-7231","authenticated-orcid":false,"given":"Michael","family":"Cieza Terrones","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Anglo American Clinic Nephrology Department, Alberto Hurtado Faculty of Medicine, Cayetano Heredia Peruvian University, Lima 15102, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-3968","authenticated-orcid":false,"given":"Thyago","family":"Proen\u00e7a de Moraes","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Department of Nephrology, Pontifical Catholic University of Paran\u00e1, Curitiba 80060-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Rodr\u00edguez Y\u00e1nez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Cartagena, Cartagena 130010, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Washington","family":"Osorio","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Department of Nephrology, Armed Forces Specialty Hospital Number 1, Quito City 170403, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyi","family":"Arellano Cabeza","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Valle, Cali 760042, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Daza","family":"Arnedo","sequence":"additional","affiliation":[{"name":"Latin American Society of Nephrology and Hypertension (SLANH), Panama City 0801, Panama"},{"name":"Colombian Association of Nephrology and Arterial Hypertension, Bogota 110221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ekir.2023.02.1082","article-title":"Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group","volume":"8","author":"Vallejos","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_2","first-page":"31","article-title":"Situaci\u00f3n de la enfermedad renal cr\u00f3nica en Am\u00e9rica Latina, con \u00e9nfasis en la enfermedad renal diab\u00e9tica: Dificultades y desaf\u00edos","volume":"22","author":"Elbert","year":"2025","journal-title":"Nefrol. Latinoam."},{"key":"ref_3","unstructured":"Fontalvo, J.R., Arnedo, R.D., Sarabia, M.R., Jim\u00e9nez, J., Montejo-Hern\u00e1ndez, J., Rodr\u00edguez-Y\u00e1nez, T., Soler, M.J., Sciarrone-Alibrandi, M.T., and Rivera, R.F. (2026). Metabolic Kidney Disease: A New Concept in the Interaction Between Obesity, Prediabetes, Diabetes and Liver Dysfunction. G. Ital. Nefrol., 43."},{"key":"ref_4","unstructured":"Vergara, A., Mart\u00ednez, A., G\u00f3rriz, J., Moreno, F., Navarro, J., and Soler, M. (2020). Enfermedad Diab\u00e9tica Renal: Albuminuria Y Progresi\u00f3n, Sociedad Espa\u00f1ola de Nefrolog\u00eda."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","article-title":"Diabetic kidney disease with and without albuminuria","volume":"20","author":"MacIsaac","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fontalvo, J.R., Arnedo, R.D., Salcedo, N.A., Alfaro, M., Torrejano, D.N., Blanco, M.C., Gulfo, I.U., Sarabia, M.R., Franco, E.A., and Cabrales, J. (2022). New evidence in the treatment of diabetic kidney disease: What is finerenone\u2019s contribution?. Rev. Colomb. Nefrol., 9.","DOI":"10.22265\/acnef.9.3.603"},{"key":"ref_7","first-page":"116","article-title":"Consenso de la Sociedad Latinoamericana de Nefrolog\u00eda e Hipertensi\u00f3n en relaci\u00f3n con el papel de los antagonistas del receptor mineralocorticoide en enfermedad renal cr\u00f3nica","volume":"19","author":"Mascheroni","year":"2022","journal-title":"Nefrol. Latinoam."},{"key":"ref_8","first-page":"1","article-title":"Mineralocorticoid Receptor Antagonists: A Comprehensive Review of Finerenone","volume":"22","author":"White","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jamacardio.2025.1101","article-title":"Finerenone in Heart Failure With Improved Ejection Fraction","volume":"10","author":"Pabon","year":"2025","journal-title":"JAMA Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"115933","DOI":"10.5527\/wjn.v15.i1.115933","article-title":"Efficacy and safety of finerenone in diabetic kidney disease: Latin American experience from FINDKDLATAM trial","volume":"15","author":"Arnedo","year":"2026","journal-title":"World J. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e076444","DOI":"10.1136\/bmjopen-2023-076444","article-title":"Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials","volume":"14","author":"Bansal","year":"2024","journal-title":"BMJ Open"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Campino, C., Martinez-Aguayo, A., Aglony, M., Garcia, H., Bancalari, R., Avalos, C., Bolte, L., A Carvajal, C., Baudrand, R., and I Owen, G. (2011). 11\u03b2-Hydroxysteroid Dehydrogenase Type 2 (11\u03b2-HSD2) Activity Decreases with Age in Normotensive Subjects. Endocr. Rev., 32.","DOI":"10.1210\/endo-meetings.2011.PART3.P9.P2-620"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.37871\/jbres1513","article-title":"Inflammation and Diabetic Kidney Disease: New Perspectives","volume":"3","author":"Jorge","year":"2022","journal-title":"J. Biomed. Res. Environ. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kolkhof, P., Jaisser, F., Kim, S.Y., Filippatos, G., Nowack, C., and Pitt, B. (2017). Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: Comparison at bench and bedside. Handbook of Experimental Pharmacology, Springer.","DOI":"10.1007\/164_2016_76"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2026). Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026. Diabetes Care, 49, S183\u2013S215.","DOI":"10.2337\/dc26-S009"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9919963","DOI":"10.1155\/ije\/9919963","article-title":"Impact of HbA1c Reduction on Major Kidney Outcomes in Type 2 Diabetes With Poor Glycemic Control and Advanced CKD","volume":"2025","year":"2025","journal-title":"Int. J. Endocrinol."},{"key":"ref_19","first-page":"3","article-title":"Recomendaciones para el manejo del riesgo cardiorrenal en el paciente con diabetes mellitus tipo 2","volume":"27","author":"Castillo","year":"2020","journal-title":"Rev. Colomb. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/M21-4776","article-title":"Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure with Reduced Ejection Fraction A Post Hoc Analysis of the DAPA-HF Trial","volume":"175","author":"Butt","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000543923","article-title":"Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform","volume":"149","author":"Kovesdy","year":"2025","journal-title":"Nephron"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/ndt\/gfac198","article-title":"Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)","volume":"38","author":"Green","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2021070942","article-title":"Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial","volume":"33","author":"Agarwal","year":"2022","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:06:01Z","timestamp":1783523161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071317"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071317","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}